Publikationen Alle Publikationen 2024 Dynamic changes in tumor profiling reveal intra- and intertumoral heterogeneity focused on an uncharacterized HER2 mutation: a case report of a young breast cancer patient Publikation ansehen (PDF) 2024 Liquid Biopsy for Detection of Pancreaticobiliary Cancers by Functional Enrichment and Immunofluorescent Profiling of Circulating Tumor Cells and Their Clusters Publikation ansehen (PDF) 2023 Profiling of circulating glial cells for accurate blood-based diagnosis of glial malignancies Publikation ansehen (PDF) 2022 Accurate Screening for Early-Stage Breast Cancer by Detection and Profiling of Circulating Tumor Cells Publikation ansehen (PDF) 2022 Case Report: Extensive Tumor Profiling in Primary Neuroendocrine Breast Cancer Cases as a Role Model for Personalized Treatment in Rare and Aggressive Cancer Types Publikation ansehen (PDF) 2021 Excellent Response With Alpelisib and Bicalutamide for Advanced Salivary Duct Carcinoma With PIK3CA Mutation and High Androgen Receptor Expression-A Case Report Publikation ansehen (PDF) 2021 Development and validation of a multigene variant profiling assay to guide targeted and immuno therapy selection in solid tumors Publikation ansehen (PDF) 2021 Improved Treatment Outcomes by Using Patient Specific Drug Combinations in Mammalian Target of Rapamycin Activated Advanced Metastatic Cancers Publikation ansehen (PDF) 2021 Angiogenesis Inhibitors in Personalized Combination Regimens for the Treatment of Advanced Refractory Cancers Publikation ansehen (PDF) 2020 Hallmark Circulating Tumor-Associated Cell Clusters Signify 230 Times Higher One-Year Cancer Risk Publikation ansehen (PDF) 2020 Evaluation of Circulating Tumor Cell Clusters for Pan-Cancer Noninvasive Diagnostic Triaging Publikation ansehen (PDF) 2020 A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancer Publikation ansehen (PDF) 2020 Clinical utility of circulating tumor‑associated cells to predict and monitor chemo‑response in solid tumors Publikation ansehen (PDF) 2020 Long Overall Survival in a Case of Refractory Stage IV Squamous Cell Carcinoma of Lung Treated with Personalized De Novo Combination Regimen Publikation ansehen (PDF) 2019 Circulating ensembles of tumor-associated cells: A redoubtable new systemic hallmark of cancer Publikation ansehen (PDF) 2019 Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers: results from the RESILIENT trial Publikation ansehen (PDF) 2019 Adaptive, Iterative, Long-Term Personalized Therapy Management in a Case of Stage IV Refractory NSCLC Publikation ansehen (PDF)
